Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib. [electronic resource]
Producer: 20100706Description: 1223-7 p. digitalISSN:- 1476-5551
- Aniline Compounds -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Cell Proliferation -- drug effects
- Drug Synergism
- Fusion Proteins, bcr-abl -- antagonists & inhibitors
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Nitriles -- therapeutic use
- Piperazines -- therapeutic use
- Proto-Oncogene Proteins c-abl -- antagonists & inhibitors
- Pyrimidines -- therapeutic use
- Quinolines -- therapeutic use
- Tumor Cells, Cultured
- src-Family Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.